ClinicalTrialsFinder
Not Yet RecruitingPhase 4ACTRN12626000398303

Daily versus alternate day oral iron therapy for treatment of iron deficiency anemia among Sultan Qaboos University students in Oman: a randomized control trial

Sponsor

Sultan Qaboos University

Enrollment

128 participants

Start Date

Jul 1, 2026

Study Type

Interventional

Conditions

Mild to Moderate iron deficiency anemia

Summary

The aim from this study is to test the hypothesis that alternate day oral iron as single dose is superior to daily single dose of oral iron in improving anemia and low side effects. This randomized open labelled controlled trial will be conducted at Student’s Clinic in Sultan Qaboos University (SQUH). It will focus on Omani female students aged between 17-25 years old with moderate iron deficiency anaemia .

Eligibility

Sex: FemalesMin Age: 17 YearssMax Age: 25 Yearss

Inclusion Criteria5

  • College students at Sultan Qaboos University in Oman.
  • Age 17-25 years old.
  • Female gender.
  • Moderate anemia of hemoglobin of 8.0- 10.9 g/dL with microcytic hypochromic anemia.
  • Low iron stores\Ferritin.

Exclusion Criteria7

  • Mild anaemia of haemoglobin levels between 11.0–11.9 g/dL as majority will not need iron supplements and usually treated with modification of diet to be iron rich diet.
  • Chronic diseases (kidney disease, chronic liver disease, cardiac failure).
  • Malignancy.
  • Hemolytic anemias (including hemoglobinopathies) .
  • Pregnancy \ Lactation .
  • Patients who received blood transfusions within past 3 months and/or suffering from severe anemia requiring transfusion were also excluded.
  • Severe iron deficiency anemia , HB: less than 7.9 g/dL

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Eligible participants will be devided into two arms\groups . Intervention arm : will receive ferrous sulphate iron supplements on alternatives days . --------- This is an open-label RCT , no placeb

Eligible participants will be devided into two arms\groups . Intervention arm : will receive ferrous sulphate iron supplements on alternatives days . --------- This is an open-label RCT , no placebo will be used . -------------- Drug : Ferrous sulphate Dose : 200mg (containing 60 mg elemental iron) Duration of administration : 12 weeks ( 3 months ) Mode of administration : oral tablets Frequency : every second day ------- Adherence will be monitored by via a questionnaire , it will be answered by the participatnts during each follow up visit .

Locations(1)

Oman

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12626000398303